Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
The Journal of Pathology
|
November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
Karim H Saba, Valeria Difilippo, Michal Kovac, et al.
Pediatric Blood & Cancer
|
February 19, 2013
Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma
Tobias M Dantonello, Christoph Int-Veen, Andreas Schuck, et al.
Oncotarget
|
May 15, 2018
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
Bushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2008
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy
Karl-Ludwig Schaefer, Martin Eisenacher, Yvonne Braun, et al.
BMC Cancer
|
June 13, 2022
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up
Georg Seifert, Sarah B Blakeslee, Gabriele Calaminus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2020
Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients
Lisa Marie Kelley, Miriam Schlegel, Stefanie Hecker-Nolting, et al.
Nature Communications
|
April 1, 2024
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Yang Zhou, Partho Sarothi Ray, Jianguo Zhu, et al.
Oncotarget
|
March 13, 2015
TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome
Sebastian Ribi, Daniel Baumhoer, Kristy Lee, et al.
Blood
|
February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options
Michael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
Haematologica
|
August 16, 2023
Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome
Miriam Erlacher, Felicia Andresen, Martina Sukova, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
The Journal of Pathology
|
November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
Karim H Saba, Valeria Difilippo, Michal Kovac, et al.
Pediatric Blood & Cancer
|
February 19, 2013
Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma
Tobias M Dantonello, Christoph Int-Veen, Andreas Schuck, et al.
Oncotarget
|
May 15, 2018
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
Bushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2008
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy
Karl-Ludwig Schaefer, Martin Eisenacher, Yvonne Braun, et al.
BMC Cancer
|
June 13, 2022
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up
Georg Seifert, Sarah B Blakeslee, Gabriele Calaminus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2020
Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients
Lisa Marie Kelley, Miriam Schlegel, Stefanie Hecker-Nolting, et al.
Nature Communications
|
April 1, 2024
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Yang Zhou, Partho Sarothi Ray, Jianguo Zhu, et al.
Oncotarget
|
March 13, 2015
TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome
Sebastian Ribi, Daniel Baumhoer, Kristy Lee, et al.
Blood
|
February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options
Michael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
Haematologica
|
August 16, 2023
Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome
Miriam Erlacher, Felicia Andresen, Martina Sukova, et al.
Page
of 9